Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-12-13
2005-12-13
Brumback, Brenda (Department: 1654)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S236100, C514S002600, C514S012200
Reexamination Certificate
active
06974578
ABSTRACT:
Method and composition for treating a patient suffering from a disease, disorder or condition and associated pain include the administration to the patient of a therapeutically effective amount of a neurotoxin selected from a group consisting of,Botulinumtoxin types A, B, C, D, E, F and G.
REFERENCES:
patent: 2373454 (1945-04-01), Bumy et al.
patent: 2719102 (1955-09-01), Baldwin
patent: 3132995 (1964-05-01), Berger et al.
patent: 4713240 (1987-12-01), Wilkins et al.
patent: 4932936 (1990-06-01), Dykstra et al.
patent: 5053005 (1991-10-01), Borodic
patent: 5055291 (1991-10-01), Lam et al.
patent: 5055302 (1991-10-01), Laties et al.
patent: 5183462 (1993-02-01), Borodic
patent: 5437291 (1995-08-01), Pasricha et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: WO9528171 (1995-10-01), None
Purngvarin et al; J. Med. Assoc. Thai. (Apr. 1992) 75 (4) 199-203.
Correspondence dated Dec. 10, 1991 Between William C. Shepherd and Ira Sanders.
Correspondence dated Apr. 13, 1992 Between Ira Sanders and Angelika S. Aswad Regarding “Animal Study”.
Partial Correspondence dated Apr. 24, 1992 Between Angelika S. Aswad and Dr. Sanders Regarding Botulinum Toxin to Decrease Salivary Flow.
Ambache, J. Physiol. (1951) 113, 1-17.
Brin. Arch. De Neurobiol. 54. Supl. 3 (7-23) 1991.
File scisearch on STN. AN No. 93:162872. Price et al. ‘A Comparative Study of Tear Secretion in Blepharospasm and Hemifacial Spasm Patients Treated With Botulinum Toxin’, J. of Clin. Neuro-Opthalmology, vol. 13, No. 1, pp. 67-71. Mar. 1993.
File Caplus on STN. DN No. 105:220509. Knight, D.E. ‘Botulinum Toxin Types A, B And D Inhibit Catecholamine Secretion From Bovine Adrenal Medullary Cells’, FEBS. Lett. vol. 207, No. 2, pp. 222-226, 1986.
Kondo et al. ‘Modification of the Action of Pentagastrin on Acid Secretion by Botulinum Toxin’, Experientia. vol. 33, No. 6, pp. 750-751, 1977.
Grusser Von O-J, Die ersten systematischen Beschreibungen und tierexperiemtellen Untersuchungen des Botulisums, Sudhoffa Archiv (1986), 70(2), 167-186. English translation attached.
Kerner, J. Das Fettgift oder die fettsaure und ihre wirkungen auf den thierischen organismus, ein beytrag zur untersuchung des in verdorbenen wursten giftig wirkenden stoffes. Stuttgart und Tubingen: Cotta, 368 pages (1822); English translation of table of contents and of Chapter 8 enclosed.
Ambache, N.;A Further Survey of the Action of Clostridium Botulinum Toxin upon Different Types of Autonomic Nerve Fibre; J. Physiol.; 1951; 113:1-17.
Jenzer, G., et al.;Type B Botulism, Report on Mild Courses with Predominantly Autonomic Nervous Impairment; Schweiz. Med. Wschr.; 104, 685-693; 1974. (English translation also enclosed).
Heneson, Nancy;Deadly Toxin Calms Excited Muscles;New Scientist, Dec. 8, 1990, p. 24.
Aoki K. Roger
Carlson Steven R.
Grayston Michael W.
Leon Judith M.
Allergan Inc.
Brumback Brenda
Donovan Stephen
Gupta Anish
LandOfFree
Method for treating secretions and glands using botulinum toxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating secretions and glands using botulinum toxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating secretions and glands using botulinum toxin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3491627